In Mission: Impossible 2, John C. McCloy is the CEO of Biocyte. Brendan Gleeson plays McCloy, whose company is central to the film’s biological-weapons plot.
Biocyte Pharmaceuticals employs Dr. Vladimir Nekhorvich, the scientist who develops the Chimera virus and its cure, Bellerophon. Rogue IMF agent Sean Ambrose wants to exploit the crisis commercially: he plans to release Chimera, then profit by controlling access to the antidote.
McCloy is blackmailed after Ambrose obtains footage showing Chimera infecting one of Nekhorvich’s colleagues. Ethan Hunt and his team later kidnap McCloy to learn more about Biocyte’s research and the available Bellerophon samples. Ambrose ultimately seeks enough Biocyte stock to become the company’s majority shareholder.
The distractor names belong to different parts of the story or are inventions. Nekhorvich Labs is not the company McCloy leads; Nekhorvich is the scientist employed by Biocyte. Medigen and BioSyn are not the answer in the film. Mission: Impossible 2 was released in 2000 and directed by John Woo.